BioMaxima S.A. (WSE:BMX)
Poland · Delayed Price · Currency is PLN 9.92
-0.08 (-0.80%)
Oct 15, 2026, 1:28 PM CET
BioMaxima Financials Overview
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 61.75 | 60.9 | 52.85 | 46.79 | 143.87 | 79.09 |
Revenue Growth | 7.27% | 15.24% | 12.96% | -67.48% | 81.91% | 29.06% |
Gross Profit Gross Profit Growth | 30.4 | 28.45 | 25.06 | 21.68 | 56.01 | 30.15 |
Operating Income Operating Income Growth | 1.95 | 1.11 | 1.27 | 0.07 | 34.9 | 13.65 |
Net Income Net Income Growth | 0.81 | 0.11 | 0.54 | 0.59 | 28.89 | 10.24 |
Earnings Per Share EPS Growth | 0.19 | 0.02 | 0.13 | 0.14 | 6.48 | 2.29 |
EPS Growth | 14.57% | -84.33% | -5.99% | -97.91% | 182.97% | 23.78% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Microbiology Microbiology Growth | 38.61 | 30.74 | 24.63 | 24.42 | 35.9 |
Analytics Analytics Growth | 20.94 | 20 | 20.21 | 117.75 | 41.82 |
Others Others Growth | 1.36 | 2.11 | 1.95 | 1.7 | 1.37 |
Total Total Growth | 60.9 | 52.85 | 46.79 | 143.87 | 79.09 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1.2 | 1.74 | 0.91 | 1.5 | 12.92 | 3.01 |
Total Debt Total Debt Growth | 13.37 | 14.46 | 14.62 | 12.86 | 5.83 | 17.27 |
Net Cash (Debt) Net Cash Growth | -12.17 | -12.72 | -13.71 | -11.36 | 7.09 | -14.26 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2.95 | -3.03 | -3.27 | -2.63 | 1.59 | -3.18 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2.01 | 3.37 | -0.15 | 1.59 | 37.07 | -0.13 |
Capital Expenditures CapEx Growth | -0.76 | -1 | -2.27 | -18.08 | -9.88 | -4.48 |
Free Cash Flow Free Cash Flow Growth | 1.25 | 2.38 | -2.42 | -16.49 | 27.19 | -4.61 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 49.23% | 46.72% | 47.42% | 46.34% | 38.93% | 38.12% |
Operating Margin | 3.15% | 1.82% | 2.41% | 0.14% | 24.26% | 17.26% |
Pretax Margin | 1.59% | 0.31% | 0.58% | 0.40% | 24.93% | 16.15% |
Profit Margin | 1.31% | 0.17% | 1.01% | 1.25% | 20.08% | 12.95% |
FCF Margin | 2.02% | 3.90% | -4.58% | -35.24% | 18.90% | -5.83% |
| Fiscal Year | FY 2022 | FY 2021 |
|---|---|---|
| Period Ending | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.450 |
Dividend Per Share Growth | 11.11% | 80.00% |
Dividend Yield | 1.95% | 1.71% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 52.37 | 481.21 | 83.86 | 117.49 | 3.68 | 11.09 |
P/FCF Ratio | 33.54 | 21.28 | - | - | 3.91 | - |
PS Ratio | 0.68 | 0.83 | 0.85 | 1.47 | 0.74 | 1.44 |